ImmuDyne, Inc. Announces Preliminary Earnings Report.HOUSTON--(BUSINESS WIRE)--Dec. 5, 1995--ImmuDyne, Inc. today announced preliminary numbers that show earnings of $.15 per share for fiscal year ending August 31, 1995 as compared to $.01 per share in fiscal year ending August 31, 1994. ImmuDyne has 18 million shares outstanding, with approximately 6 million shares in the float. The substantial increase in earnings over the last year can be attributed to sales in the skin care industry, the sale of manufacturing facility MDH MDH Minnesota Department of Health MDH Mälardalens Högskola (Swedish) MDH Malate Dehydrogenase MDH Manila Doctors' Hospital MDH Carbondale, IL, USA - Southern Illinois Airport (Airport Code) Laboratories, the sub-licensing of a portion of ImmuDyne's technology, increase in royalties, and the successful settlement of all seven of ImmuDyne's patent infringement lawsuits. According to Mr. James D. Wood, Chairman, "we have built a strong base in the cosmetic industry and have repeatedly confirmed the validity of our skin care patents. We look forward to continuing to develop sales in the aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production. , human nutritional, cholesterol reduction, and animal nutritional industries, as well as many other areas. Our macrophage macrophage /mac·ro·phage/ (mak´ro-faj) any of the large, mononuclear, highly phagocytic cells derived from monocytes that occur in the walls of blood vessels (adventitial cells) and in loose connective tissue (histiocytes, phagocytic technology has a number of potential applications in these very profitable industries." ImmuDyne has recently received attention through the announcement of preliminary studies using their product IMMUSTIM for the prevention of the deadly Taura Syndrome in shrimp. ImmuDyne Inc. is listed on the NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). Automated Bulletin Board with the symbol IMMD IMMD Immediate IMMD Institut für Mathematische Maschinen und Datenverarbeitung . ImmuDyne, Inc. is a Texas-based biotechnology company (symbol IMMD) specializing in macrophage technology with offices in Houston, Texas and Palo Alto, California “Palo Alto” redirects here. For other uses, see Palo Alto (disambiguation). Palo Alto (IPA: /ˌpæloʊˈʔæltoʊ/, from Spanish: palo: "stick" and alto: "high", i.e. . It owns rights to technology relating to cosmetic, pharmaceutical, nutritional, veterinary and agricultural uses. CONTACT: ImmuDyne, Inc., Houston James D. Wood, 415/949-3864 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion